Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 AUD | +11.11% | -13.04% | -45.95% |
02-29 | Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study | MT |
02-29 | Radiopharm Theranostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Chart calendar Radiopharm Theranostics Limited
Upcoming events on Radiopharm Theranostics Limited
Past events on Radiopharm Theranostics Limited
14/04/2024 | Extraordinary Shareholders Meeting |
03/04/2024 15:40 | MedInvest Biotech & Pharma Investor Conference |
20/03/2024 22:00 | NWR VirtualHealthcare Conference |
11/03/2024 | European Molecular Imaging Meeting |
29/02/2024 | B. Riley Securities Radiopharma Investor Conference |
29/02/2024 03:42 | Q2 2024 Earnings Release |
30/01/2024 23:12 | December 2023 Sales and Revenue Release - Activities Report |
15/11/2023 23:00 | Annual General Meeting |
14/11/2023 | Bell Potter Healthcare Conference |
02/11/2023 | The Capital Network's Emerging ASX Gems investment conference |
30/10/2023 23:30 | Business Update Call |
30/10/2023 23:27 | September 2023 Sales and Revenue Release - Activities Report |
31/08/2023 02:38 | Q4 2023 Earnings Release |
17/08/2023 | Extraordinary Shareholders Meeting |
31/07/2023 00:40 | June 2023 Sales and Revenue Release - Activities Report |
14/06/2023 02:00 | Business Update Call |
27/04/2023 06:05 | March 2023 Sales and Revenue Release - Activities Report |
02/04/2023 | Jefferies Radiopharma Innovation Summit |
23/03/2023 | Wholesale Investor Emergence Conference |
20/03/2023 22:00 | NWR Virtual Healthcare Conference |
Annual results
Fiscal Period | Juni | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,19 0,29 -34.91% | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -12,4 -12,3 -0.66% | -20,2 -15,0 -34.3% | -28,3 |
EBIT Million USD | Released Forecast Spread | 0,00 | -14,4 -16,3 11.41% | -22,3 -17,2 -29.58% | -29,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -20,9 -22,2 6.08% | -22,4 -17,5 -27.8% | -29,0 |
Net income Million USD | Released Forecast Spread | -0,35 | -20,9 -22,2 5.98% | -22,4 -17,5 -27.85% | -29,0 |
EPS USD | Released Forecast Spread | 0,00 | -0,12 -0,08 -37.18% | -0,07 -0,06 -25.86% | -0,07 |
Announcement Date | 23/11/21 | 30/08/22 | 31/08/23 | - |
Quarterly results
Fiscal Period | June | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,10 0,00 - | 0,09 0,00 - | 0,20 | 0,00 0,19 - | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -14,6 -8,54 -70.41% | ||||||||||
Net income Million USD | Released Forecast Spread | -8,48 | -14,3 -8,54 -67.26% | |||||||||
EPS USD | Released Forecast Spread | -0,03 | ||||||||||
Announcement Date | 28/11/22 | 28/02/23 | 28/02/23 | 31/08/23 | - | 29/02/24 | - | - | - | - | - |
Past sector events for Radiopharm Theranostics Limited
03/05/2024 12:07 | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
03/05/2024 11:00 | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
02/05/2024 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
02/05/2024 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
02/05/2024 21:01 | AMGEN INC.: Q1 2024 Earnings Release |
02/05/2024 18:43 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
02/05/2024 12:30 | ORGANON & CO.: Q1 2024 Earnings Release |
02/05/2024 12:00 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
02/05/2024 06:30 | NOVO NORDISK A/S: Q1 2024 Earnings Release |
01/05/2024 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RAD Stock
- Calendar Radiopharm Theranostics Limited